CD5 and melanoma: Moreover, CD5-deficient mice engrafted with B16-F10 melanoma cells displayed slower tumor growth compared to wild-type (WT) C57BL/6 mice, which was associated with tumor infiltration by T cells exhibiting a more activated phenotype and enhanced antitumor effector functions [17].